Stockscreener 앱 받기
3.33%
시간 외 거래:
전일 마감가:
$291.09
열려 있는:
$287.98
하루 거래량:
4.68M
Relative Volume:
1.53
시가총액:
$150.96B
수익:
$33.42B
순이익/손실:
$4.09B
주가수익비율:
37.27
EPS:
7.55
순현금흐름:
$10.39B
1주 성능:
-9.18%
1개월 성능:
-14.04%
6개월 성능:
-12.34%
1년 성능:
+5.61%
1일 변동 폭
$269.67
$288.52
1주일 범위
$267.40
$312.11
52주 변동 폭
$253.30
$346.85
암젠 Stock (AMGN) Company Profile
명칭
Amgen Inc
전화
(805)447-1000
주소
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
AMGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
281.41 | 150.96B | 33.42B | 4.09B | 10.39B | 7.55 |
|
LLY
Lilly Eli Co
|
720.91 | 647.50B | 45.04B | 10.59B | 414.30M | 11.71 |
|
JNJ
Johnson Johnson
|
148.69 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
ABBV
Abbvie Inc
|
174.20 | 308.16B | 56.33B | 4.28B | 17.83B | 2.40 |
|
NVO
Novo Nordisk Adr
|
61.21 | 271.71B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
NVS
Novartis Ag Adr
|
103.40 | 204.22B | 51.72B | 11.94B | 13.81B | 5.88 |
암젠 Stock (AMGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Outperform |
| 2024-10-14 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-05-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 재개 | Raymond James | Mkt Perform |
| 2024-02-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-02 | 업그레이드 | Truist | Hold → Buy |
| 2023-10-20 | 재개 | JP Morgan | Neutral |
| 2023-10-17 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 재개 | BofA Securities | Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-04-24 | 재확인 | Oppenheimer | Outperform |
| 2023-03-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 재확인 | Truist | Buy |
| 2022-11-18 | 개시 | Credit Suisse | Underperform |
| 2022-10-31 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-02-09 | 재확인 | Barclays | Equal Weight |
| 2022-02-09 | 재확인 | Jefferies | Buy |
| 2022-02-09 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 재확인 | Oppenheimer | Outperform |
| 2022-02-09 | 재확인 | Wells Fargo | Equal Weight |
| 2022-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-09-23 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 개시 | Daiwa Securities | Buy |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-10-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | 업그레이드 | Truist | Hold → Buy |
| 2020-10-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | 다운그레이드 | Truist | Buy → Hold |
| 2020-10-08 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 재개 | Guggenheim | Neutral |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-03-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-17 | 재개 | Morgan Stanley | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-11-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-19 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-05-23 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
암젠 주식(AMGN)의 최신 뉴스
33,756 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by Arrowstreet Capital Limited Partnership - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Position Boosted by Russell Investments Group Ltd. - MarketBeat
Quantum Case Study: Merck, Amgen, Deloitte, and QuEra Tackle Clinical Trial Prediction - HPCwire
STATUS List 2025: Nancy Hopkins, Boston Biotech Working Group - statnews.com
Amgen’s Uplizna deepens response through 1 year in myasthenia gravis - PharmaLive
Abacus FCF Advisors LLC Grows Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Straightline Group LLC Buys Shares of 1,421 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bank of Nova Scotia Acquires 311,604 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Shelton Capital Management Sells 90,975 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
GMP Biologics Market Top Companies StudyAmgen Inc., F. - openPR.com
Fmr LLC Sells 561,092 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Biopharmaceuticals Global Overview Report 2025: Global Market to Reach $698.7 Billion by 2030, Fueled by Specialized Therapies, Such as mAb and Gene Treatments, & a Strong Pipeline - GlobeNewswire Inc.
The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb - TradingView
Amgen (NASDAQ:AMGN) Upgraded at StockNews.com - MarketBeat
Buy Amgen Stock. The Company Is Getting Into the Obesity Drug Business. - Barron's
Amgen Inc. (NASDAQ:AMGN) Stock Position Raised by Ilmarinen Mutual Pension Insurance Co - MarketBeat
Landscape Capital Management L.L.C. Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Prudential PLC - MarketBeat
Wellington Management Group LLP Has $76.54 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Unlocking Disease: Amgen’s Omics Approach Advances Targeted Treatments - Amgen
Behcet’s Disease Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Soligenix, Chugai Pharma, UMC Utrecht, Ganzhou Hemay Pharma, Amgen - The Globe and Mail
Morgan Stanley Adjusts Price Target on Amgen to $330 From $328, Keeps Equalweight Rating - MarketScreener
Amgen Says CEO Robert A. Bradway's 2024 Total Compensation Was $24.4 Million - MarketScreener
Canopy Partners LLC Purchases 1,662 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Cerity Partners LLC Sells 6,135 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bank of Montreal Can Buys 46,030 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bell Asset Management Ltd Boosts Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Trump Hints At 'Major Tariff' On Imported Pharmaceuticals: Pfizer, Eli Lilly, Amgen And Other Stocks Tumble In Wednesday Pre-Market - Benzinga
U S Wealth Group LLC. Purchases New Shares in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Invesco Ltd. Increases Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Purchased by Trek Financial LLC - MarketBeat
Arete Wealth Advisors LLC Grows Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Yoffe Investment Management LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
OneAscent Financial Services LLC Buys 2,096 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - MSN
Amgen's Ian Thompson On Leadership And A Global Mindset - Life Science Leader
Leeward Financial Partners LLC Makes New Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Goldman Sachs Adjusts Amgen Price Target to $408 From $370, Maintains Buy Rating - MarketScreener
Amgen’s SWOT analysis: biotech giant’s stock poised for growth amid obesity drug potential - Investing.com
45 Years of Amgen - Amgen
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Federated Hermes Inc. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Unigestion Holding SA - MarketBeat
Peapack Gladstone Financial Corp Trims Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Quadrant Capital Group LLC - MarketBeat
Envestnet Asset Management Inc. Has $330.26 Million Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
Huntington National Bank Grows Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Pitcairn Co. Has $3.86 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
(AMGN) Proactive Strategies - news.stocktradersdaily.com
P/E Ratio Insights for Amgen - Benzinga
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Payden & Rygel - MarketBeat
암젠 (AMGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.66%
자본화:
|
볼륨(24시간):